Articles published by Regeneron Pharmaceuticals, Inc.![]() Via GlobeNewswire
Tickers
REGN
![]() Via GlobeNewswire
Tickers
REGN
![]() Via GlobeNewswire
Tickers
REGN
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() Via GlobeNewswire
Tickers
REGN
![]() Via GlobeNewswire
Tickers
REGN
![]() ![]() ![]() ![]() ![]() ![]() ![]() Via GlobeNewswire
Tickers
REGN
![]() ![]() ![]() ![]() ![]()
Linvoseltamab BLA for Treatment of Relapsed/Refractory Multiple Myeloma Accepted for FDA Priority Review
February 21, 2024
Via GlobeNewswire
Tickers
REGN
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|
Articles published by Regeneron Pharmaceuticals, Inc.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|